VTV241018P169000
- 2.10
- 0.000.00%
Vanguard Value ETF Newsroom
J&J Submits Supplemental BLA for Darzalex Faspro to FDA
Procter & Gamble Analyst Ratings
Home Depot Analyst Ratings
CVS Health in Focus as Activist Investor Prepares for High-Level Talks
Johnson & Johnson Analyst Ratings
Today's Pre-Market Movers and Top Ratings | STLA, CVS, NIO and More
Robinhood To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Monday
Here Are the Medicare Part D Drugs Expected to Face 2025 Price Negotiations
J&J, Legend Report Carvykti Cut Death Risk by 45% in Multiple Myeloma Study
J&J Releases Encouraging Data on Talvey Combination Therapies
Johnson & Johnson's CARVYKTI Is The First And Only Cell Therapy To Significantly Extend Overall Survival Versus Standard Therapies For Patients With Multiple Myeloma As Early As Second Line; 45% Reduction In Risk Of Death Achieved With CARVYKTI After...
Home Depot's Options: A Look at What the Big Money Is Thinking
Walmart Analyst Ratings
Hurricane Helene Update: 28 Dead, Power Outages, Insurance Damages And More
Costco's Latest Quarter Shows Its Business Model Continues To Work Beautifully
Retail Pair Trade: Walmart Lands a Street-high PT From Citi, Dollar General Is Cut to Sell
Today's Pre-Market Movers and Top Ratings | COST, DG, BMBL, HPQ and More
Johnson & Johnson Announces Updated Results From The Investigational Phase 1b Trimm-2 Study Evaluating The Combination Of TALVEY And DARZALEX FASPRO Based Combination Shows Deep And Durable Responses In Patients With Relapsed Or Refractory Multiple...
J&J Snaps Six Straight Sessions of Losses
'Walmart Said It Plans To Install High-Tech Automaton From Artificial Intelligence-Based Supply Chain Technology Company Symbiotic In Two Of Its Regional Distribution Centers One In Buckeye, Ariz., And Another In Searcy, Ark.' - ChainStoreAge